Document Type
Article
Publication Date
11-2022
Abstract
Machine learning applications promise to augment clinical capabilities and at least 64 models have already been approved by the US Food and Drug Administration. These tools are developed, shared, and used in an environment in which regulations and market forces remain immature. An important consideration when evaluating this environment is the introduction of open-source solutions in which innovations are freely shared; such solutions have long been a facet of digital culture. We discuss the feasibility and implications of open-source machine learning in a health care infrastructure built upon proprietary information. The decreased cost of development as compared to drugs and devices, a longstanding culture of open-source products in other industries, and the beginnings of machine learning–friendly regulatory pathways together allow for the development and deployment of open-source machine learning models. Such tools have distinct advantages including enhanced product integrity, customizability, and lower cost, leading to increased access. However, significant questions regarding engineering concerns about implementation infrastructure and model safety, a lack of incentives from intellectual property protection, and nebulous liability rules significantly complicate the ability to develop such open-source models. Ultimately, the reconciliation of open-source machine learning and the proprietary information–driven health care environment requires that policymakers, regulators, and health care organizations actively craft a conducive market in which innovative developers will continue to both work and collaborate.
Recommended Citation
Harish, Keerthi B., W Nicholson Price II, and Yindalon Aphinyanaphongs. "Open-Source Clinical Machine Learning Models: Critical Appraisal of Feasibility, Advantages, and Challenges." Journal of Medical Internet Research 6, no. 4 (2022). DOI: http://dx.doi.org/10.2196/33970
Included in
Artificial Intelligence and Robotics Commons, Health Law and Policy Commons, Science and Technology Law Commons
Comments
All journals published by JMIR Publications provide immediate open access to their content on the principle that making research freely available to the public supports a greater global exchange of knowledge and accelerates research. Copyright is retained by the authors, and articles can be freely used and distributed by others. Articles are distributed under the terms of the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published by JMIR Publications, is properly cited. The complete bibliographic information (authors, title, journal, volume/issue, and article ID), a link to the original publication (URL), and this copyright and license information (“Licensed under Creative Commons Attribution cc-by 4.0”) must be included.